Dashboard Vaccines & Biosimilars
Vaccines & Biosimilars
| SL | BRAND | MANUFACTURER | GENERIC | INC DATE/Approval DATE | VALID DATE | REJECTED DATE | SUSPENDED DATE | WITHDRAW DATE | SMPC | TECH RPT | ATTACH | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Covovax | Serum Institute of India Pvt. Ltd. | SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine | 0000-00-00 | 2022-02-22 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 2 | Comirnaty | Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium. | Tozinameran-COVID-19 mRNA vaccine (nucleoside modified) | 2021-06-03 | 2021-06-03 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 3 | Moderna Covid-19 Vaccine | Moderna TX Inc. | mRNA-1273 | 0000-00-00 | 2021-06-29 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|
||
| 4 | COVID-19 Vaccine Janssen | Janssen-Cilag International NV, Belgium | Ad26.COV2.S | 0000-00-00 | 2021-06-15 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 5 | CoronaVac | Sinovac Life Sciences Co., Ltd. No. 21, Tianfu Street, Daxing Biomedicine Industrial Base of Zhongguancun Science Park, Daxing District, Beijing, P.R | COVID-19 Vaccine (Vero Cell), Inactivated | 0000-00-00 | 2021-06-06 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|
||
| 6 | Zhong Al Ke Wei/ COVILO. | Beijing Institute of Biological Products Co, Ltd. Room 205, Second Floor, Building 4, No 9 Boxing 2nd Road, Economic- Technological Development Area, | Inactivated SARS-CoV-2 virus (19nCoV-CDC-Tan-HB02 strain) | 0000-00-00 | 2021-04-28 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|
||
| 7 | Sputnik V | GENERIUM Joint-Stock company (GENERIUM JSC), located at 273, Zavodskaya street, Volginsky, Petushinsky District, Vladimir Region, 601125 | rAd26 and rAd5 adenoviral vector vaccine, which have been modified to contain the SARS-CoV-2 spike protein | 0000-00-00 | 2021-04-27 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|
||
| 8 | Covishield | Serum Institute of India Pvt. Ltd. | ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) | 0000-00-00 | 2021-01-08 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|
||
| 9 | Act-HIB | Sanofi Pasteur S A, France | Haemophilus Influenzae Type B Polysaccjarode 10 ug/dose | 1997-10-29 | 2017-10-28 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 10 | Imovax Polio Injection | Sanofi Aventis Pasteur SA, France | Inactivated Poliovirus Type-1 Ph. Eur 40 antigen D unit Inactivated Poliovirus Type-2 Ph. Eur 8 antigen D Unit Inactivated Poliovirus Type-3 Ph. Eur 32 antigen D unit | 2019-05-06 | 2025-01-24 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 11 | Pentaxim | Sanofi Pasteur, France | Diptheria Toxoid 30 IU Tetanus Toxoid 40 IU Bordetella Pertusis Antigens Toxoid 25 mcg Filamentous Haemagglutinin 25 mcg Inactivated Type 1 Poliomyelitis Virus 40 DU Inactivated Type 2 Poliomylit | 2006-02-05 | 2021-02-04 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 12 | Okavax | The Research Foundation for Microbial Disease of Osaka University, Japan | An attenuated live Varicella-zoster Virus 1400 PFU+ Sodium Chloride 1.6mg+Potassium Chloride 0.04mg+Monobasic Potassium Phosphate 0.4mg+ Dibasic Sodium Phosphate hydrate 4.395mg+Sucrose 35mg+Monosodiu | 2009-06-21 | 2014-06-20 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 13 | TETRAct-HIB | Sanofi Pasteur S A, France | Haemophilus Influenza type b polysaccharide conjugated to tetanus Protein 10mcg+Purified diphtheria toxoid 30IU+Purified tetanus toxoid 60IU+Bordetella pertussis 4IU/0.5ml | 2009-06-21 | 2014-06-20 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 14 | RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) | Merck Sharp & Dohme Corp., USA | G1 Reassortant INN ?2.2 x 106 IU/Dose G2 Reassortant INN ?2.8 x 106 IU/Dose G3 Reassortant INN ?2.2 x 106 IU/Dose G4 Reassortant INN ?2.0 x 106 IU/Dose P1 Reassortant INN ?2.3 x 106 IU/Dose | 2014-04-27 | 2024-04-27 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 15 | GARDASIL (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine) | Merck Sharp & Dohme Corp., USA | Type 6L1 protein INN 20 µg Type 11L1 protein INN 40 µg Type 16L1 protein INN 40 µg Type 18L1 protein INN 20 µg | 2014-04-27 | 2024-04-27 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 16 | Vaxigrip Tetra Quadvivalent Influenza vaccine | Sanofi Pasteur S A, France | -A/Michigan/45/2015 (H1N1) pdm 09-like Strain (A/Michigan/45/2015, NYMC x-275 -A/Hong Kong/4801/2014 (H3N2)-Like Strain (A/Hong Kong/4801/2014, NYMC x-263B) -B/Brishane/60/2008-Like strain (B/Bri | 2019-05-06 | 2024-05-05 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 17 | Tetraxim | Sanofi Pasteur, Parc Industriel d’Incarville 27100 Val de Reuil France, Marketing Authorization Holder (MAH): Sanofi Pasteur, 14 Espace Henry Vallee | Diphtheria toxoid ? 30 IU Tetanus Toxoid ? 40 IU Bordetella pertussis antigens: Toxoid 25?g Filamentous haemagglutinin 25?g Inactivated type 1 Poliomyelitis virus 40DU Inactivated type 2 Poliomy | 2020-10-11 | 2025-10-10 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 18 | Prevenar 13 | Pfizer Ireland Pharmaceuticals, Grange Castle, Business Park Clondalkin, Dublin-22, Ireland (also responsible for quality control and primary packagin | Pneumococcal Polysaccharide serotype Ph. Eur. 1,3,4,5,6A, 6B, 7F,9V,14,18C,19A,19F,23F | 2020-12-10 | 2025-12-09 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|
||
| 19 | Prevenar 13 (Vaccine) | Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium. | Pneumococcal polysaccharide serotype (13-valent, adsorbed) | 2020-02-25 | 2025-02-24 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 20 | Nimenrix | GlaxoSmithKline Biologicals S.A., Belgium for Pfizer Limited, United Kingdom Batch releasing site: Pfizer manufacturing Belgium NV, Rijksweg 12, B-2 | Neisseria meningitidis group A polysaccharide 5mcg + Neisseria meningitidis group C polysaccharide 5mcg+ Neisseria meningitidis group W-135 polysaccharide 5mcg+ Neisseria meningitidis group Y polysacc | 2018-11-06 | 2023-11-05 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 21 | VARIVAX | Merck Sharp & Dohme Corp, USA | Oka/Merck Varicella Virus INN 1350 PFU (Plaque-forming units) | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 22 | Pneumovax 23 (Pneumococcal Vaccine Polyvalent) | Pneumococcal Polysaccharide INN 25mcg/dose of each type | 2014-04-27 | 2024-04-26 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
||||
| 23 | MENUMONE-A/C/Y/W-135 | Sanofi Pasteur Inc., USA | Meningococcal Polysacharide of Neisseria Meningitis Gr. A 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. B 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. C 50µg + Menin | 2013-01-31 | 2018-01-30 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 24 | MENUMONE-A/C/Y/W-135 | Sanofi Pasteur Inc., USA | Meningococcal Polysacharide of Neisseria Meningitis Gr. A 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. B 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. C 50µg + Menin | 2013-01-31 | 2018-01-30 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 25 | Vaxigrip Enfants | Sanofi Pasteur S A, France | A/California/7/2009(H1N1)-derived Strain Used NYMC X-179A 7.5 Micrograms HA**+ A/Perth/16/2009 (H3N2)-Like strain used NYMC X-187 Derived from A/Victoria/210/2009 7.5 Micrograms HA**+ B/Brisbane/60/20 | 2012-01-23 | 2017-01-22 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 26 | Prevenar 13 | Jhon Wyeth & Brother Ltd. UK and Marketing Authorisation Holder Wyeth Lederle Vaccine SA Belgium | Pneumococcal Polysaccharide serotype 1 2.2µg + Pneumococcal Polysaccharide serotype 3 2.2µg + Pneumococcal Polysaccharide serotype 4 2.2µg + Pneumococcal Polysaccharide serotype 5 2.2µg + Pneumoc | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 27 | BCG-Medac | Medac Gesellschaft fur Klinische spezialpraparate Germany | Bacillus calmette-Guerin strain (seed RIVM derived from Seed 1173-p2) at least 2x108 and not more than 2x109 Viable units | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 28 | Stamaril | Sanofi Pasteur, France | Yellow fever Virus 17 D-204 Strain (Live attenuated) ? 1000 LD50 units | 2019-05-06 | 2024-05-05 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 29 | Vaxigrip | Sanofi Pasteur S A, France | A.Brisbane/59/2007(H1N1) 15mcgHA+ A/Brisbane/10/2007(H3N2) 15mcgHA+ B/Florida/4/2006 15mcgHA/0.5ml in P.F.S | 2019-05-06 | 2024-05-05 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 30 | Pneumo-23 | Sanofi Pasteur S A, France | Purified capsular polysaccharides of Streptococcus pneumoniae 1,2,3,4,5.6B, 7F,8,9N,9V,10A, 11A,12F,14, 15B,17F, 18C, 19A,19F,20,22F,23F, 33F for Each of the 23 serotypes 25mcg/ 0.5ml in P.F.S | 2010-02-16 | 2020-02-15 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 31 | TETRAct-HIB | Sanofi Pasteur S A, France | Haemophilus Influenza type b polysaccharide conjugated to tetanus Protein 10mcg+Purified diphtheria toxoid 30IU+Purified tetanus toxoid 60IU+Bordetella pertussis 4IU/0.5ml | 1997-10-29 | 2017-10-28 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 32 | Favirab | Sanofi Aventis Pasteur, France | F(ab’)2 Fragment of equine antirabes immune globulin/ml 200-400 IU | 2008-02-11 | 2018-01-11 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 33 | Avaxim 80 IU Pediatric | Aventis Pasteur S.A., France | Inactivated Hepatitis A Virus Ph. Eur. 80 antigen units | 2019-05-06 | 2024-06-19 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 34 | Avaxim, Inactivated Hepatitis A Vaccine | Sanofi Pasteur S A, France | Inactivated Hepatitis A Virus | 2004-01-17 | 2019-01-16 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 35 | Inj. Tetabulin (Tetanus Immunoglobulin Human 250IU) | Baxter AG, Austria | Tetanus Antitoxin 250IU | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 36 | Typhim VI | Sanofi Pasteur S A, France | Purified Vi capsular polysaccharide of salmonella Typhi (Ty 2 strain) 0.025 mg/dose | 2019-05-06 | 2022-10-28 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 37 | Act-HIB | Sanofi Pasteur S A, France | Haemophilus Influenzae Type B Polysaccjarode 10 ug/dose | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 38 | Varilrix Vaccine | Sanofi Pasteur S A, France | Live Attenuated Varicella Virus Vaccine OKA Strain | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 39 | Trimovax Injection | Sanofi Pasteur S A, France | Vaccinum Morbillorum Vivum, measles, mumps, rubella | 1997-04-27 | 2017-04-26 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 40 | Maningococcal Polysaccharide Vaccine A+C | Pasteur Merieux Serums and Vaccines, France | Maningococcal Polysaccharide Vaccine A+C | 1996-05-12 | 2016-05-11 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 41 | Hepavax Gene | Berna Biotech, Korea | Hepatitis B Vaccine | 0000-00-00 | 2013-03-13 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 42 | Human Antitetanus Immune Globulin Grifols 250 IU Injection | Instituto Grifols S.A., Spain | Human Antitetanus Immune Globulin 250 IU | 0000-00-00 | 2010-05-08 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 43 | Verorab | Sanofi Pasteur S A, France | Rabies Virus | 2019-05-06 | 2026-08-17 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 44 | Rabipur | Chiron Behring Vaccine Pvt. Ltd. | Rabies Virus 2.5 IU | 0000-00-00 | 2015-09-01 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
| SL | BRAND | MANUFACTURER | GENERIC | INC DATE/Approval DATE | VALID DATE | REJECTED DATE | SUSPENDED DATE | WITHDRAW DATE | SMPC | TECH RPT | ATTACH | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Teta-fix 0.5ml | Healthcare Pharma | Adsorbed Tetanus Toxoid Vaccine | 2021-05-23 | 2022-01-13 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | Rabivax (Lyophilized vaccine Injection) | Popular Pharmaceuticals Ltd. | Rabies Vaccine | 0000-00-00 | 2011-03-15 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | Hepavax-B Injection | Popular Pharmaceuticals Ltd. | Hepatitis B Vaccine (rDNA) BP | 0000-00-00 | 2011-02-20 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | HPvax Injection | Popular Pharmaceuticals Ltd. | Recombinant Human Papilomavirus Vaccine (Type 16, 18) BP | 0000-00-00 | 2022-02-08 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Mvax ACYW Polysaccharide Vaccine | Popular Pharmaceuticals Ltd. | Meningococcal Polysaccharide vaccine Group ACYW135 BP 20o microgram/vial | 0000-00-00 | 2020-01-20 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Prenovax 23 Vaccine | Incepta Vaccine Limited. | Pneumococcal Polysaccharide vaccine 23 serotype | 0000-00-00 | 2022-06-09 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | Influvax Tetra Vaccine | Incepta Vaccine Limited. | Inactivated Influenza Vaccine (Quadrivalent) | 0000-00-00 | 2020-11-25 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Papilovax Vaccine | Incepta Vaccine Limited. | Human papilomavirus bi valent | 0000-00-00 | 2021-10-03 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Varizost Vaccine | Incepta Vaccine Limited. | Varicella vaccine (Live, attenuated) | 0000-00-00 | 2018-02-25 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Rubavax M Vaccine | Incepta Vaccine Limited. | Measles and Rubella vaccine | 0000-00-00 | 2015-03-24 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Vaxitet Vaccine 5ml | Incepta Vaccine Limited. | Adsorbed Tetanus Vaccine BP | 0000-00-00 | 2016-01-12 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Rabix - VC Vaccine | Incepta Vaccine Limited. | Rabies Vaccine (Human) BP | 0000-00-00 | 2011-02-14 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Vaxitet Vaccine | Incepta Vaccine Limited. | Adsorbed Tetanus Vaccine BP | 0000-00-00 | 2011-02-14 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Ingovax ACWY Vaccine 5ML | Incepta Vaccine Limited. | Meningococcal Polysaccharide Vaccine | 0000-00-00 | 2016-03-24 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Ingovax ACWY Vaccine (0.5ml) | Incepta Vaccine Limited. | Meningococcal Polysaccharide Vaccine | 0000-00-00 | 2011-02-14 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Cholvax Vaccine | Incepta Vaccine Limited. | Inactivated Oral Cholera Vaccine | 0000-00-00 | 2020-01-08 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | Hepa-B Vaccine (For Paediatric) | Incepta Vaccine Limited. | Hepatitis B Vaccine (rDNA) BP | 0000-00-00 | 2011-02-14 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | Hepa-B Vaccine (For Adult) | Incepta Vaccine Limited. | Hepatitis B Vaccine (rDNA) | 0000-00-00 | 2011-02-14 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | PrevaHAV Vaccine (For Pediatric) | Incepta Vaccine Limited. | Inactivated Hepatitis A Vaccine BP 250U /0.5ml | 0000-00-00 | 2017-02-20 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | PrevaHAV Vaccine(for adult) | Incepta Vaccine Limited. | Inactive Hepatitis A Vaccine BP | 2022-05-08 | 2027-02-20 | 0000-00-00 | 0000-00-00 | 0000-00-00 | ||||
| 1 | TT Vax Injection | Popular Pharmaceuticals Ltd. | Adsorbed Tetanus Vaccine (Tetanus toxoid | 2011-02-13 | 2026-07-01 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|
|||
| 1 | Vaxphoid Vaccine | Incepta Vaccine Limited. | Typhoid polysaccharide vaccine BP (Vi capsular Polysaccharide of Salmonella typhi Ty2 strain Ready to fill bulk | 0000-00-00 | 2011-02-14 | 0000-00-00 | 0000-00-00 | 0000-00-00 |
|